title: 2013 viral clearance symposia - session 5. Conference summary: key discussion and outcomes, pending questions, and proposed experiments.
authors.affiliation: Paul-Ehrlich-Institut; and david_roush@merck.com Johannes.Bluemel@pei.de.
authors.forename: Johannes
authors.initials: J
authors.lastname: Blümel
authors.affiliation: Merck, Sharp and Dohme, Inc. david_roush@merck.com Johannes.Bluemel@pei.de.
authors.forename: David
authors.initials: D
authors.lastname: Roush
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D002626:Chemistry, Pharmaceutical / Q000379:methods / Q000639:trends*; D003226:Congresses as Topic / Q000639:trends*; D006801:Humans; D009515:New Jersey; D012107:Research Design / Q000639:trends; D019562:Viral Load / Q000187:drug effects* / Q000502:physiology
chemical_list: D000998:Antiviral Agents